Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000891554-02-002031
Filing Date
2002-04-12
Accepted
2002-04-12 00:00:00
Documents
1
Period of Report
2002-05-23

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d02-37111.txt DEF 14A 215221
  Complete submission text file 0000891554-02-002031.txt   216741
Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Filer) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21589 | Film No.: 02608828
SIC: 2834 Pharmaceutical Preparations